Katherine D Vickery1,2,3, Paul J Novotny4, Becky R Ford1, Kiley Lantz4, Silvio Kavistan1, Davinder Singh4,5, Valentina Hernandez5, Irene G Sia4, Mark L Wieland4. 1. Health, Homelessness, and Criminal Justice Lab, Hennepin Healthcare Research Institute, Minneapolis, Minnesota. 2. Division of General Internal Medicine, Hennepin Healthcare, Minneapolis, Minnesota. 3. Health Care for the Homeless, Hennepin County Public Health Department, Minneapolis, Minnesota. 4. Department of Medicine, Mayo Clinic, Rochester, Minnesota, and Phoenix, Arizona. 5. Mountain Park Health Center, Phoenix, Arizona.
Abstract
PURPOSE: The purpose of this study was to characterize the material, health (general and diabetes-specific), and social impacts of the COVID-19 pandemic on Hispanic adults with type 2 diabetes who did not experience COVID-19 infection. METHODS: This cross-sectional and longitudinal study used surveys within a clinical trial of 79 Hispanic adult clinic patients with type 2 diabetes. Cross-sectional measures included the Coronavirus Anxiety Scale, items from the Coronavirus Impact Scale, and the Pandemic Impacts Inventory. Longitudinal measures included the Summary of Diabetes Self-Care, health care utilization, and measures of diabetes self-efficacy, social support, and quality of life. RESULTS: Participants were majority low-income, Spanish-speaking females with poor diabetes control. Coronavirus anxiety was low despite majority of participants having an affected family member and frequent access barriers. More than half of participants reported moderate/severe pandemic impact on their income. Diabetes self-care behaviors did not change between prepandemic and pandemic measures. Diabetes self-efficacy and quality of life improved despite fewer diabetes-related health care visits. CONCLUSIONS: Despite high levels of access barriers, financial strain, and COVID-19 infection of family members, Hispanic adults with type 2 diabetes continued to prioritize their diabetes self-management and demonstrated substantial resilience by improving their self-efficacy and quality of life.
PURPOSE: The purpose of this study was to characterize the material, health (general and diabetes-specific), and social impacts of the COVID-19 pandemic on Hispanic adults with type 2 diabetes who did not experience COVID-19 infection. METHODS: This cross-sectional and longitudinal study used surveys within a clinical trial of 79 Hispanic adult clinic patients with type 2 diabetes. Cross-sectional measures included the Coronavirus Anxiety Scale, items from the Coronavirus Impact Scale, and the Pandemic Impacts Inventory. Longitudinal measures included the Summary of Diabetes Self-Care, health care utilization, and measures of diabetes self-efficacy, social support, and quality of life. RESULTS: Participants were majority low-income, Spanish-speaking females with poor diabetes control. Coronavirus anxiety was low despite majority of participants having an affected family member and frequent access barriers. More than half of participants reported moderate/severe pandemic impact on their income. Diabetes self-care behaviors did not change between prepandemic and pandemic measures. Diabetes self-efficacy and quality of life improved despite fewer diabetes-related health care visits. CONCLUSIONS: Despite high levels of access barriers, financial strain, and COVID-19 infection of family members, Hispanic adults with type 2 diabetes continued to prioritize their diabetes self-management and demonstrated substantial resilience by improving their self-efficacy and quality of life.
Entities:
Keywords:
COVID-19; immigrant and refugee health; social determinants of health; type 2 diabetes
Authors: Safiya Richardson; Jamie S Hirsch; Mangala Narasimhan; James M Crawford; Thomas McGinn; Karina W Davidson; Douglas P Barnaby; Lance B Becker; John D Chelico; Stuart L Cohen; Jennifer Cookingham; Kevin Coppa; Michael A Diefenbach; Andrew J Dominello; Joan Duer-Hefele; Louise Falzon; Jordan Gitlin; Negin Hajizadeh; Tiffany G Harvin; David A Hirschwerk; Eun Ji Kim; Zachary M Kozel; Lyndonna M Marrast; Jazmin N Mogavero; Gabrielle A Osorio; Michael Qiu; Theodoros P Zanos Journal: JAMA Date: 2020-05-26 Impact factor: 56.272
Authors: Mark L Wieland; Jane W Njeru; Marcelo M Hanza; Deborah H Boehm; Davinder Singh; Barbara P Yawn; Christi A Patten; Matthew M Clark; Jennifer A Weis; Ahmed Osman; Miriam Goodson; Maria D Porraz Capetillo; Abdullah Hared; Rachel Hasley; Laura Guzman-Corrales; Rachel Sandler; Valentina Hernandez; Paul J Novotny; Jeff A Sloan; Irene G Sia Journal: Diabetes Educ Date: 2017-06-07 Impact factor: 2.140
Authors: Juliana C N Chan; Lee-Ling Lim; Nicholas J Wareham; Jonathan E Shaw; Trevor J Orchard; Ping Zhang; Eric S H Lau; Björn Eliasson; Alice P S Kong; Majid Ezzati; Carlos A Aguilar-Salinas; Margaret McGill; Naomi S Levitt; Guang Ning; Wing-Yee So; Jean Adams; Paula Bracco; Nita G Forouhi; Gabriel A Gregory; Jingchuan Guo; Xinyang Hua; Emma L Klatman; Dianna J Magliano; Boon-Peng Ng; David Ogilvie; Jenna Panter; Meda Pavkov; Hui Shao; Nigel Unwin; Martin White; Constance Wou; Ronald C W Ma; Maria I Schmidt; Ambady Ramachandran; Yutaka Seino; Peter H Bennett; Brian Oldenburg; Juan José Gagliardino; Andrea O Y Luk; Philip M Clarke; Graham D Ogle; Melanie J Davies; Rury R Holman; Edward W Gregg Journal: Lancet Date: 2020-11-12 Impact factor: 79.321
Authors: Justin M Gregory; James C Slaughter; Sara H Duffus; T Jordan Smith; Lauren M LeStourgeon; Sarah S Jaser; Allison B McCoy; James M Luther; Erin R Giovannetti; Schafer Boeder; Jeremy H Pettus; Daniel J Moore Journal: Diabetes Care Date: 2020-12-02 Impact factor: 17.152
Authors: Jane W Njeru; Christi A Patten; Marcelo M K Hanza; Tabetha A Brockman; Jennifer L Ridgeway; Jennifer A Weis; Matthew M Clark; Miriam Goodson; Ahmed Osman; Graciela Porraz-Capetillo; Abdullah Hared; Allison Myers; Irene G Sia; Mark L Wieland Journal: BMC Public Health Date: 2015-12-29 Impact factor: 3.295